AVDL
Avadel Pharmaceuticals
AVDL
AVDL
Delisted
AVDL was delisted on the 11th of February, 2026.
187 hedge funds and large institutions have $1.22B invested in Avadel Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 58 increasing their positions, 61 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
8% more funds holding
Funds holding: 173 → 187 (+14)
5% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 61
1.84% less ownership
Funds ownership: 84.2% → 82.36% (-1.8%)
Holders
187
Holding in Top 10
8
Calls
$31M
Puts
$18.9M
Top Buyers
| 1 | +$15.5M | |
| 2 | +$13.9M | |
| 3 | +$8.4M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$6.84M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.72M |
Top Sellers
| 1 | -$48.2M | |
| 2 | -$13.6M | |
| 3 | -$10.2M | |
| 4 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$7.11M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$6.12M |